ISELIN, N.J., Oct. 10, 2018 — UBM Life Sciences Group’s Pharmaceutical Executive announced honorees of the 2018 Emerging Pharma Leaders awards program as it prepared to recognize the group of 10 up-and-coming professionals in its October issue.
This year marked the tenth year that Pharmaceutical Executive elevated individuals exhibiting knowledge, skills and other qualities to make tough decisions facing manufacturers today.
“In the pharmaceutical industry, we can see more clearly than ever in this year’s annual Emerging Pharma Leaders selections that the industry is changing with the times,” said Lisa Henderson, editor-in-chief of Pharmaceutical Executive. “This year features more titles that didn’t exist five years ago, and more diverse paths these professionals took to get to their current position.”
Pharmaceutical Executive received more than 100 nominations for the award between April and June. It made its final 10 selections through a blinded process by three members of the Pharmaceutical Executive Editorial Advisory Board and a previous Emerging Pharma Leaders honoree. Judging criteria was based on current role, progression of career, education and extracurricular activities to enhance leadership, and specific case examples.
The 2018 Emerging Pharma Leaders are, in alphabetical order:
Christopher Boone, Pfizer Inc. Hong Cheng, Sanofi Kathryn Corzo, Sanofi Greg Griesemer, G&W Liz Lewis, Takeda Oncology Shao-Lee Lin, Horizon Pharma Bernat Olle, Vedanta Biosciences Nadeem Rehmat, PharmEvo Pvt. Ltd Raymond Sanchez, Otsuka Pharmaceutical Harout Semerjian, Ipsen
“These leaders join a distinguished group of Emerging Pharma Leaders,” said Group Publisher Todd Baker. “They represent some of the best and brightest in the pharma industry and we look forward to following their accomplishments in the coming years.”
Interviews with each of the honorees are available online now.
About UBM Life Sciences Group Life Sciences Group is a U.S.-based event, information, and marketing services business serving professional communities in human healthcare, veterinary medicine, and the pharmaceutical industry with an unmatched portfolio of in-person, print, and digital products. Reaching over 2 million life sciences professionals monthly, Life Sciences Group enables the professional communities it serves to learn, connect, and conduct business. It is organized by UBM, which in June 2018 combined with Informa plc to become a leading B2B information services group and the largest B2B Events organizer in the world.
Media Contact: UBM Life Sciences Group Amy Erdman Vice President, Marketing [email protected] (203) 523-7041